RxPG News Feed for RxPG News

Medical Research Health Special Topics World
  Home
 
   Health
 Aging
 Asian Health
 Events
 Fitness
 Food & Nutrition
 Happiness
 Men's Health
 Mental Health
 Occupational Health
 Parenting
 Public Health
 Sleep Hygiene
 Women's Health
 
   Healthcare
 Africa
 Australia
 Canada Healthcare
 China Healthcare
 India Healthcare
 New Zealand
 South Africa
 UK
  NHS
 USA
 World Healthcare
 
   Latest Research
 Aging
 Alternative Medicine
 Anaethesia
 Biochemistry
 Biotechnology
 Cancer
 Cardiology
 Clinical Trials
 Cytology
 Dental
 Dermatology
 Embryology
 Endocrinology
 ENT
 Environment
 Epidemiology
 Gastroenterology
 Genetics
 Gynaecology
 Haematology
 Immunology
 Infectious Diseases
 Medicine
 Metabolism
 Microbiology
 Musculoskeletal
 Nephrology
 Neurosciences
 Obstetrics
 Ophthalmology
 Orthopedics
 Paediatrics
 Pathology
 Pharmacology
 Physiology
 Physiotherapy
 Psychiatry
 Radiology
 Rheumatology
 Sports Medicine
 Surgery
 Toxicology
 Urology
 
   Medical News
 Awards & Prizes
 Epidemics
 Launch
 Opinion
 Professionals
 
   Special Topics
 Ethics
 Euthanasia
 Evolution
 Feature
 Odd Medical News
 Climate

Last Updated: Oct 11, 2012 - 10:22:56 PM
NICE UK Channel

subscribe to UK newsletter
Healthcare : UK

   EMAIL   |   PRINT
NICE asked to develop guidance on new treatments for breast and lung cancer, Crohn’s disease, ulcerative colitis, obesity and rheumatoid arthritis.

Feb 8, 2007 - 5:34:09 AM , Reviewed by: Dr. Rashmi Yadav
"We are keen to begin developing guidance that will help to inform their decisions about treatment and healthcare in these areas as soon as possible and we will publish details of the timetables for these topics on our web site shortly.”

 
[RxPG]
NICE asked to develop guidance on new treatments for breast and lung cancer, Crohn’s disease, ulcerative colitis, obesity and rheumatoid arthritis.
NICE has also been asked to appraise adalimumab for moderate to severely active Crohn%u2019s disease.
The National Institute for Health and Clinical Excellence (NICE) today welcomes the announcement of additional topics for its forward work programme. Topics including new treatments for breast and lung cancer, Crohn’s disease, ulcerative colitis, obesity and rheumatoid arthritis, have been referred to NICE by the Secretary of State for Health in line with the national priorities they have established for the NHS.

The following topics have been referred:

• 2 clinical guidelines on:
o Rheumatoid arthritis in adults
o Diarrhoea and vomiting in children

• 1 rapid clinical guideline on:
o Acutely ill patients in hospital

• 5 technologies for appraisal as part of NICE’s rapid single technology appraisal (STA) programme on:
o Bevacizumab for non-small cell lung cancer
o Certolizumab pegol for rheumatoid arthritis
o Infliximab for ulcerative colitis
o Lapatinib for advanced or metastatic breast cancer
o Rimonabant for the treatment of obese and overweight patients

• 3 technologies for appraisal as part of NICE’s multiple technology appraisal (MTA) programme on:
o Endovascular stents for abdominal aortic aneurysms
o Machine versus cold (static) storage of donated kidneys
o Spinal cord stimulation for chronic pain

In addition, NICE has also been asked to appraise adalimumab for moderate to severely active Crohn’s disease. It has not yet been confirmed whether this will be appraised as part of the Institute’s MTA or STA programmes.

Commenting on the referrals, Andrew Dillon, NICE Chief Executive said: “NICE welcomes the referral of today’s topics, which address areas of significant concern for those working in the NHS, patients and carers. We are keen to begin developing guidance that will help to inform their decisions about treatment and healthcare in these areas as soon as possible and we will publish details of the timetables for these topics on our web site shortly.”



Advertise in this space for $10 per month. Contact us today.


Related UK News
Leading OCD expert welcomes Charles Walker MP's honesty
British court orders force-feeding for dying anorexic woman
Systematic bias in the assessment of UK doctors
Why women in UK can't find sperm donors?
Britain reviews child protection after toddler's death by torture
Most British Women Unaware of Lifestyle Stroke Risks
Depression is wrongly seen as natural part of getting older
Drink and drugs fuel Scottish suicide and homicide rates
NRI doctor guilty of unethical tests on British patients
Healthcare commissioning- ?Adverse to patient care

Subscribe to UK Newsletter

Enter your email address:


 About Dr. Rashmi Yadav
This news story has been reviewed by Dr. Rashmi Yadav before its publication on RxPG News website. Dr. Rashmi Yadav, MBBS, is a senior editor for RxPG News. In her position she is responsible for managing special correspondents and the surgery section of the website. Her areas of special interest include cardiothoracic surgery and interventional radiology.
RxPG News is committed to promotion and implementation of Evidence Based Medical Journalism in all channels of mass media including internet.
 Additional information about the news article
About NICE
3. The National Institute for Health and Clinical Excellence (NICE) is the independent organisation responsible for providing national guidance on the promotion of good health and the prevention and treatment of ill health.
4. NICE produces guidance in three areas of health:
public health – guidance on the promotion of good health and the prevention of ill health for those working in the NHS, local authorities and the wider public and voluntary sector
health technologies – guidance on the use of new and existing medicines, treatments and procedures within the NHS
clinical practice – guidance on the appropriate treatment and care of people with specific diseases and conditions within the NHS.
 Feedback
For any corrections of factual information, to contact the editors or to send any medical news or health news press releases, use feedback form

Top of Page

 
Contact us

RxPG Online

Nerve

 

    Full Text RSS

© All rights reserved by RxPG Medical Solutions Private Limited (India)